SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-19-000032
Filing Date
2019-05-09
Accepted
2019-05-08 19:17:25
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-q12019x10q.htm 10-Q 1016829
2 EXHIBIT 10.1 mgen-q12019xex101yale.htm EX-10.1 225400
3 EXHIBIT 31.1 mgen-q12019xex311.htm EX-31.1 12675
4 EXHIBIT 31.2 mgen-q12019xex312.htm EX-31.2 12783
5 EXHIBIT 32.1 mgen-q12019xex321.htm EX-32.1 15140
  Complete submission text file 0001590750-19-000032.txt   4857062

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20190331_def.xml EX-101.DEF 207338
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20190331_pre.xml EX-101.PRE 301308
8 XBRL INSTANCE DOCUMENT mgen-20190331.xml EX-101.INS 729744
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20190331.xsd EX-101.SCH 41100
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20190331_lab.xml EX-101.LAB 511877
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20190331_cal.xml EX-101.CAL 59821
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 19808328
SIC: 8071 Services-Medical Laboratories